CRISPR Therapeutics AG(NASDAQ:CRSP) 
CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious human diseases. The company develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), a gene editing technolo...
Website: http://www.crisprtx.com
Founded: 1987
Full Time Employees: 458 (Dec 2022)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 32.00
H 32.99
L 30.98
C 32.65
V 3,076,063
10EMA 32.65
20EMA 32.65
60EMA 32.65
120EMA 32.65
250EMA 32.65